Patents by Inventor Patricia Lowden

Patricia Lowden has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220241414
    Abstract: Featured herein are pharmaceutical compositions and formulations containing an interleukin-6 (IL-6) antagonist, e.g., an IL-6 antibody molecule, designed for administration for a subject. The pharmaceutical compositions and formulations provided herein are suitable for use in manufacture of medicaments or methods of treating subjects with IL-6 associated diseases, e.g., ocular diseases associated with elevated levels of IL-6.
    Type: Application
    Filed: August 31, 2021
    Publication date: August 4, 2022
    Inventors: Grigorios Zarbis-Papastoitsis, Patricia Lowden
  • Patent number: 10799589
    Abstract: Featured herein are vehicle formulations and formulations containing a chimeric cytokine designed for e.g., ocular delivery.
    Type: Grant
    Filed: August 7, 2017
    Date of Patent: October 13, 2020
    Assignee: BUZZARD PHARMACEUTICALS AB
    Inventors: Gregory Zarbis-Papastoitsis, Patricia Lowden, Byeong Chang
  • Publication number: 20190046642
    Abstract: Featured herein are pharmaceutical compositions and formulations containing an interleukin-6 (IL-6) antagonist, e.g., an IL-6 antibody molecule, designed for administration for a subject. The pharmaceutical compositions and formulations provided herein are suitable for use in manufacture of medicaments or methods of treating subjects with IL-6 associated diseases, e.g., ocular diseases associated with elevated levels of IL-6.
    Type: Application
    Filed: February 23, 2017
    Publication date: February 14, 2019
    Inventors: Grigorios Zarbis-Papastoitsis, Patricia Lowden
  • Publication number: 20180177877
    Abstract: Featured herein are vehicle formulations and formulations containing a chimeric cytokine designed for e.g., ocular delivery.
    Type: Application
    Filed: August 7, 2017
    Publication date: June 28, 2018
    Inventors: Gregory Zarbis-Papastoitsis, Patricia Lowden, Byeong Chang
  • Publication number: 20140308239
    Abstract: Featured herein are vehicle formulations and formulations containing a chimeric cytokine designed for e.g., ocular delivery.
    Type: Application
    Filed: March 13, 2014
    Publication date: October 16, 2014
    Applicant: ELEVEN BIOTHERAPEUTICS, INC.
    Inventors: Gregory Zarbis-Papastoitsis, Patricia Lowden, Byeong Chang